Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;20(5):886-890.
doi: 10.2174/1570159X19666211202150041.

Neurosteroid Modulation of GABAA Receptor Function by Independent Action at Multiple Specific Binding Sites

Affiliations

Neurosteroid Modulation of GABAA Receptor Function by Independent Action at Multiple Specific Binding Sites

Lei Wang et al. Curr Neuropharmacol. 2022.

Abstract

Neurosteroids are endogenous modulators of GABAA receptors that mediate anxiety, pain, mood and arousal. The 3-hydroxyl epimers, allopregnanolone (3α-OH) and epiallopregnanolone (3β-OH) are both prevalent in the mammalian brain and produce opposite effects on GABAA receptor function, acting as positive and negative allosteric modulators, respectively. This Perspective provides a model to explain the actions of 3α-OH and 3β-OH neurosteroids. The model is based on evidence that the neurosteroid epimers bind to an overlapping subset of specific sites on GABAA receptors, with their net functional effect on channel gating being the sum of their independent effects at each site.

Keywords: GABAA receptors; Neurosteroids; affinity labeling; desensitization; ion channels; structural biology.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Structure and actions of neurosteroids. Allopregnanolone (3α5α-P; top left) is an endogenous PAM neurosteroid characterized by a 3α-hydroxyl group. Its epimer, epi-allopregnanolone (3β5α-P; top right), is a NAM neurosteroid characterized by a 3β-hydroxyl group. The lower panels show simulated electrophysiological tracings of GABAA-receptor currents constructed using a three-state (resting-active-desensitized) Monod-Wyman-Changeux model (simulation performed in ChanneLab™ ver. 2 software provided by Stephen F. Traynelis, Emory University School of Medicine). At low open probability (PA), (left lower panel) 3α5α-P significantly potentiates the channel activation elicited by a low concentration of the orthosteric agonist GABA, whereas 3β5α-P (not shown) has no effect. In contrast, at high PA (such as that produced by a saturating concentration of GABA) 3α5α-P weakly (lower middle panel) and 3β5α-P substantially desensitize the receptor, thus inhibiting the steady-state current.
Fig. (2)
Fig. (2)
Models of neurosteroid binding sites on α1β3 GABAA receptors and the effects of their occupancy on channel gating. (Top left) Ribbon diagram of the interface between the β3(+) (salmon) and α1(-) (blue) subunits of a GABAA receptor (based on pdb 6HUO) with the neurosteroid 3α5α-P in its preferred docking poses in: an intra-β-subunit site between β3(V290) on TM3 and β3(Y442) on TM4; a β3(+)/α1(-) intersubunit site between α1(Q242), α1(W246) on TM1 and β3(F301) on TM3 and; an intra-α-subunit site between α1(V227) on TM1 and α1(Y411 and N408) on TM4. (Top right) Hydrophobic surface representation of 3α5α-P docked to the α1β3 GABAA receptor (brown most and turquoise least hydrophobic) illustrating that neurosteroids bind between the hydrophobic transmembrane α-helices on the receptor surface, interacting with both protein and annular lipid. (Lower panel) Cartoon illustrating that 3α5α-P (yellow steroid) occupancy of the β3(+)/α1(-) intersubunit site and/or the intra-α1-subunit site promotes channel activation. In contrast, occupancy of the intra-β3-subunit site by either 3α5α-P or 3β5α-P (blue steroid) and occupancy of the intra-α1-subunit site by 3β5α-P inhibits the receptor by promoting desensitization.

Similar articles

Cited by

References

    1. Tuem K.B., Atey T.M. Neuroactive steroids: Receptor interactions and responses. Front. Neurol. 2017;8:442. doi: 10.3389/fneur.2017.00442. - DOI - PMC - PubMed
    1. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 1986;232(4753):1004–1007. doi: 10.1126/science.2422758. - DOI - PubMed
    1. Wang M., He Y., Eisenman L.N., Fields C., Zeng C.M., Mathews J., Benz A., Fu T., Zorumski E., Steinbach J.H., Covey D.F., Zorumski C.F., Mennerick S. 3beta-hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J. Neurosci. 2002;22(9):3366–3375. doi: 10.1523/JNEUROSCI.22-09-03366.2002. - DOI - PMC - PubMed
    1. Majewska M.D., Mienville J.M., Vicini S. Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci. Lett. 1988;90(3):279–284. doi: 10.1016/0304-3940(88)90202-9. - DOI - PubMed
    1. Belelli D., Lambert J.J. Neurosteroids: Endogenous regulators of the GABA(A) receptor. Nat. Rev. Neurosci. 2005;6(7):565–575. doi: 10.1038/nrn1703. - DOI - PubMed